PI
CMD

PEAK6 Investments’s Cantel Medical Corporation CMD Stock Holding History

PEAK6 Investments’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,100
Closed -$407K – 6133
2021
Q1 		$407K Sell
5,100
-1,000
-16% -$78.1K ﹤0.01% 3388
2020
Q4 		$481K Sell
6,100
-5,200
-46% -$305K ﹤0.01% 3109
2020
Q3 		$497K Buy
11,300
+6,100
+117% +$301K ﹤0.01% 2860
2020
Q2 		$230K Buy
5,200
+3,700
+247% +$138K ﹤0.01% 3292
2020
Q1 		$54K Buy
+1,500
New +$85.3K ﹤0.01% 3568
2019
Q3 		– Sell
-2,000
Closed -$161K – 4519
2019
Q2 		$161K Buy
+2,000
New +$141K ﹤0.01% 2965
2019
Q1 		– Sell
-7,000
Closed -$521K – 4853
2018
Q4 		$521K Sell
7,000
-500
-7% -$41.3K ﹤0.01% 2304
2018
Q3 		$690K Buy
+7,500
New +$714K ﹤0.01% 2306

PEAK6 Investments's CMD Position: Q2 2021 in Review

PEAK6 Investments sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,507 shares — an estimated $120K sold.

PEAK6 Investments first reported a position in CMD in Q3 2018 and held it in 7 quarters. The position peaked at $1.94M in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • PEAK6 Investments reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • PEAK6 Investments sold 1,507 Cantel Medical Corporation shares in Q2 2021, an estimated $120K.
  • PEAK6 Investments first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 7 quarters.
  • PEAK6 Investments's Cantel Medical Corporation position peaked at $1.94M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.